IMBiologics - Latest News and Information
Technology Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
IMBiologics Corp. is a biotechnology company specializing in the development of innovative treatments for immunology, inflammation diseases, and cancer. The company utilizes advanced platforms like the multivalent antibody platform technology ePENDY and focuses on novel modalities including bispecific antibodies. IMBiologics operates primarily in immuno-oncology and autoimmune & inflammatory disease therapies.
No recent news for this company.
